Tonix Pharmaceuticals Holding Corp.
Company Stats
- Market Cap
- $167.1M
- as of Sep 30, 2026
- Shares Outstanding
- 17.2M
- Free Float
- 94.5%
Income Statement
- Revenue
- $13.1M
- Operating Income
- -$125.7M
- Net Income
- -$124.0M
- EBITDA
- -$123.8M
- FCF Margin, 3Y Avg
- -935.7%
- FCF Margin, Worst Year
- -1414.8%
Cash Flow
- Free Cash Flow
- -$103.2M
- FCF Yield
- -61.8%
- Owner FCF Yield
- -65.4%
Balance Sheet
- Cash & Equivalents
- $207.6M
Returns & Capital
- Share Repurchases
- $13.8M
- SBC, 3Y Avg
- $6.7M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $13.1M | -$103.2M | -787.5% |
| FY2024 | $10.1M | -$61.0M | -604.8% |
| FY2023 | $7.8M | -$109.9M | -1414.8% |
| FY2022 | — | -$146.2M | — |
| FY2021 | — | -$110.9M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges